Whether you are developing a glass biochip for inhouse use, or as a commercial product, cost-of-good (COGs) has always been at the top of consideration list. Key to managing COGs is the ability to keep costs as low as possible in small quantities whilst still taking advantage of economy of scale as demand increases. This is particularly challenging with customized glass chips.

When it comes to managing and mitigating product development risk, there are six guiding principles that are proven to work.

Taking a long-term view at the outset of the cartridge development program is critical for reducing the cost of goods (COGS) when the time inevitably comes to ramp up manufacturing volume.

Edward Wilkinson, Vice President of SCHOTT MINIFAB USA and Head of Strategy, explains why a fully integrated bioscience and engineering approach is the key to risk mitigation.